St. Jude proceeds with first U.S. trial of hypertension device

06/7/2013 | MassDevice.com (Boston)

The FDA has granted St. Jude Medical an investigational device exemption to conduct the first U.S. clinical study of its EnligHTN multielectrode device, which uses radiofrequency energy to disrupt the renal nerves believed to control blood pressure. The trial will involve about 590 patients with drug-resistant hypertension.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR